Therapeutic potential of fulvic acid in chronic inflammatory diseases and diabetes

Open-access review published in the Journal of Diabetes Research (2018), examining fulvic acid as a therapeutic compound in chronic inflammatory diseases. The diabetes focus in the title is secondary to the mechanistic review, which covers ROS (reactive oxygen species) scavenging, chelation, and anti-inflammatory signalling pathways that are relevant well beyond metabolic disease.

What It Covers

Three mechanism classes are examined:

Antioxidant and ROS scavenging: Fulvic acids neutralise reactive oxygen species through electron transfer, acting as free radical scavengers. This is the mechanism behind the antioxidant claims cited across the substances and applications pages. ROS accumulation is implicated in skin aging, UV damage, and chronic inflammation — which is why antioxidant capacity is therapeutically relevant rather than just cosmetically appealing.

Chelation: Fulvic acids bind metal ions, including pro-oxidant transition metals (iron, copper) that would otherwise catalyse free-radical reactions. The chelating action reduces metal-catalysed oxidative stress. This is the same mechanism that underlies the “heavy metal sequestration” aspect of peat therapy, though Winkler and Ghosh examine it in the context of systemic inflammation.

Anti-inflammatory activity: Fulvic acids modulate inflammatory signalling pathways, reducing pro-inflammatory cytokine production. The review connects this to chronic inflammatory disease management — a broader framing than the skin-focused literature but with clear relevance to the joint inflammation and eczema evidence presented elsewhere on this site.

Limitations and Context

This paper covers fulvic acids as a compound class, not peat-derived fulvic acids specifically. The diabetes application is mechanistically plausible but remains largely preclinical — the review does not report large human trials for FA in diabetes management. For the purposes of this site, the mechanistic review of antioxidant and anti-inflammatory activity is the relevant content, not the diabetes framing.